Baxter launches new Artiss fibrin sealant product

Baxter has announced the launch of Artiss, a new fibrin sealant for tissue adherence in plastic, reconstructive and burn surgery.

The product, which has now been made available in the UK, is the first premixed, ready-to-use slow-setting sealant specifically designed to seal and adhere to subcutaneous tissue in these applications, while also aiding the process of haemostasis.

At present, the use of staples and sutures in surgical procedures of this kind can leave a dead space beneath tissue flaps or skin grafts, which can lead to conditions arising from post-operative fluid accumulation, such as haematoma or seroma.

Artiss has been clinically proven to help eliminate this dead space and has been shown to be both effective and well-tolerated among a range of patients.

Baxter's hospital products business unit director Andy Goldney said: "This further enhances the range of products that we offer to the NHS within our biosurgery business to enhance and speed up recovery of patients who have undergone surgery."

Last month, the company announced the completion of its takeover of Baxa Corporation, a specialist developer of pharmacy technology that enhances the effectiveness of dose preparation and delivery.